Tsuyoshi Takeda Selected Research

Stents

5/2022	Long-term outcomes of endoscopic double stenting using an anti-reflux metal stent for combined malignant biliary and duodenal obstruction.
7/2021	A novel laser-cut fully covered metal stent with anti-reflux valve in patients with malignant distal biliary obstruction refractory to conventional covered metal stent.
6/2021	A case of endoscopic ultrasound-guided hepaticogastrostomy for obstructive jaundice caused by intraductal papillary mucinous neoplasm-associated pancreatobiliary fistula.
12/2020	A case of percutaneous transhepatic portal vein stent placement and endoscopic injection sclerotherapy for duodenal variceal rupture occurring during chemotherapy for unresectable perihilar cholangiocarcinoma.
11/2020	Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer.
11/2020	Double stenting with EUS-CDS using a new anti-reflux metal stent for combined malignant biliary and duodenal obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsuyoshi Takeda Research Topics

Disease

37	Osteoporosis 08/2021 - 01/2002
25	Bone Resorption 08/2021 - 01/2002
18	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 01/2018
14	Metabolic Bone Diseases (Osteopenia) 01/2021 - 01/2002
10	Back Pain (Backache) 08/2021 - 01/2003
8	Neoplasms (Cancer) 09/2022 - 01/2002
8	Hip Fractures (Intertrochanteric Fractures) 01/2018 - 01/2006
6	Stroke (Strokes) 01/2021 - 01/2004
6	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2004
6	Postmenopausal Osteoporosis 01/2012 - 09/2003
6	Body Weight (Weight, Body) 01/2011 - 01/2002
4	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2002
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2021 - 01/2016
4	Alzheimer Disease (Alzheimer's Disease) 01/2012 - 05/2008
4	Osteoporotic Fractures 01/2011 - 09/2003
4	Vitamin K Deficiency 01/2011 - 10/2003
4	Pain (Aches) 06/2009 - 01/2002
4	Osteogenesis Imperfecta (Lobstein Disease) 06/2005 - 01/2002
3	Duodenal Obstruction 05/2022 - 11/2020
3	Cholangitis 05/2022 - 11/2020
3	Pathologic Constriction (Stenosis) 01/2022 - 12/2020
3	Intervertebral Disc Displacement (Herniated Disc) 01/2011 - 08/2006
2	Sarcopenia 07/2021 - 04/2021
2	Rheumatoid Arthritis 05/2021 - 09/2013
2	Anorexia 04/2021 - 01/2021
2	Pancreatitis 01/2021 - 11/2020
2	Vitamin D Deficiency 01/2021 - 01/2004
2	Type 2 Diabetes Mellitus (MODY) 03/2011 - 01/2011
2	Knee Osteoarthritis 01/2011 - 03/2010
2	Hyperparathyroidism 01/2011 - 08/2009
2	Magnesium Deficiency (Deficiency, Magnesium) 12/2006 - 04/2006
1	Hyperplasia 05/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2022
1	Turcot syndrome 01/2022
1	Carcinogenesis 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Enteritis 10/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 10/2021
1	Adenocarcinoma 10/2021
1	Neutropenia 07/2021
1	Cachexia 07/2021
1	Hemobilia 07/2021
1	Disease Progression 07/2021

Drug/Important Bio-Agent (IBA)

32	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2021 - 01/2002
18	Vitamin K 2 (Vitamin K2)IBA 01/2021 - 01/2003
17	Risedronic Acid (Actonel)FDA LinkGeneric 05/2021 - 10/2003
14	Etidronic Acid (HEDP)FDA LinkGeneric 01/2012 - 01/2002
11	Diphosphonates (Bisphosphonates)IBA 01/2021 - 10/2003
11	Collagen Type I (Type I Collagen)IBA 01/2011 - 01/2002
10	Gemcitabine FDA Link 10/2021 - 01/2019
10	alfacalcidolIBA 01/2011 - 01/2002
9	menatetrenoneIBA 01/2021 - 09/2003
8	GlucocorticoidsIBA 05/2021 - 06/2005
8	CalciumIBA 01/2011 - 07/2004
7	130-nm albumin-bound paclitaxelIBA 08/2021 - 05/2020
7	Vitamin D FDA LinkGeneric 01/2021 - 01/2004
7	EnzymesIBA 12/2018 - 01/2002
7	OsteocalcinIBA 09/2012 - 01/2002
6	folfirinoxIBA 08/2021 - 05/2020
6	ImmunosorbentsIBA 12/2005 - 01/2002
5	Pharmaceutical PreparationsIBA 03/2021 - 01/2004
5	Raloxifene Hydrochloride (Evista)FDA Link 01/2012 - 01/2006
5	Alkaline PhosphataseIBA 01/2011 - 01/2002
5	Parathyroid Hormone (Parathormone)IBA 11/2007 - 01/2004
4	Calcitriol (Calcijex)FDA LinkGeneric 01/2019 - 06/2005
2	MetalsIBA 05/2022 - 11/2020
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2003
2	Anabolic AgentsIBA 01/2011 - 09/2003
2	MineralsIBA 08/2009 - 12/2006
2	elcatoninIBA 06/2009 - 01/2002
2	Ibandronic Acid (Boniva)FDA Link 11/2007 - 05/2006
2	StrontiumIBA 11/2007 - 05/2006
2	Glutamic Acid (Glutamate)FDA Link 10/2003 - 09/2003
1	Codon (Codons)IBA 09/2022
1	Formaldehyde (Formol)FDA Link 09/2022
1	ParaffinIBA 09/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	obinutuzumabIBA 12/2021
1	Bendamustine Hydrochloride FDA Link 12/2021
1	dihydrouracilIBA 10/2021
1	UracilIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2021
1	SodiumIBA 05/2021

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 09/2022 - 08/2009
6	Stents 05/2022 - 11/2020
6	Therapeutics 08/2021 - 01/2008
4	Neoadjuvant Therapy 09/2022 - 11/2020
3	Self Expandable Metallic Stents 05/2022 - 11/2020
3	Conservative Treatment 01/2011 - 08/2006
2	Enteral Nutrition (Feeding, Tube) 01/2021 - 04/2020
2	Aftercare (After-Treatment) 11/2010 - 06/2003
2	Activities of Daily Living (ADL) 12/2003 - 01/2002
1	Pancreatectomy 09/2022
1	Adjuvant Chemotherapy 05/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2021
1	Immunotherapy 07/2021
1	Catheters 06/2021